Leveraging Our Expertise to Unleash
the Potential of Personalized Medicine

Supports major multiple myeloma personalized medicine programs

Committed Advocates Supporting
Positive Growth in the Clinical Trials Industry

Actively participates in industry forums

Passionately Committed to Oncology
Drug Development

Dedicated to the discovery of new oncology treatments

Powerful Clinical Research Meets Innovation

ACT Oncology (ACT) is an oncology-specialty, full-service clinical research organization (CRO). We specialize in providing outstanding, cost-effective and responsive oncology drug development support for biotech, pharmaceutical and non-profit oncology organizations. Our team of clinical research experts is dedicated to supporting our Sponsors’ Phase I-III oncology programs, registries and Investigator Sponsored Trials, across numerous solid tumor and soft tissue cancer types.

Founded by Patricia Devitt, Pharm. D., in 2000, with corporate headquarters in Flemington, New Jersey and Madrid, Spain, ACT is a certified Woman Business Enterprise by the state of New Jersey.Our CRAs and Project Managers are regionally based throughout North America with affiliates throughout Western Europe, CEE, Asia-PAC, Latin America and Australia – enabling us to efficiently manage global studies under the direction of our expert Global Project Directors. 

Recruiting, training and retaining the best oncology professionals in the industry is a top priority for ACT. We have been remarkably successful at attracting and retaining outstanding personnel who share a common passion for oncology research and a commitment to client service. Our Project Management staff has an average of 18 years of industry experience and our negligible turnover rate of less than 2 percent since the company’s inception in 2000 ensures that this wealth of experience is available to our Sponsors through stable and consistent project teams. Our specialty model provides our clients with expert, personalized attention, not always found when working with large and non-therapeutically focused CROs.

Sponsors frequently come to ACT to rescue failing oncology trials from both large CROs and other oncology specialty CROs. Our focus on adherence to quality in oncology trials, our people, our clients and commitment to advancing oncology treatments has led to ACT's growth, with uncompromised service delivery.

ACT Oncology is Hiring! 

ACT Oncology provides excellent clinical trial services to our clients.  As a result, we are experiencing tremendous growth and looking for various types of experienced individuals to join our Team. 

Please view our current openings under "About Us."


As a founding principle, we have an uncompromising passion for quality. It is who we are.


We believe that integrity is an essential asset. We will always do the right thing.

Client Champion

We are advocates of our Sponsors’ goals for the advancement of oncology treatment options.